Start

Direct acquisition; Oligonucleotides for PCR (primers and probes)

Ausschreibungsinformationen

TED EU

VADSØ, Norway

Art
25
Verfahren
neg-wo-call
Referenznummer
541818-2025
CPV
38000000

Helse Bergen HF and with options for Helse Stavanger HF and Helse Førde HF have the intention to enter into framework agreements with two vendors, TIB Molbiol Syntheselabor GmbH and Life Technologies AS for Oligonucleoti

Alle Ausschreibungsinformationen anzeigen

Dokumente

Alle wichtigen Termine anzeigen